View |
|
DR-XY40235
|
Tranexamic Acid
|
Tranmed
|
100mg/mL (500mg/5mL)
|
Solution For Injection (IM/IV)
|
Antifibrinolytic
|
Medchem International Limited
|
India
|
Automatic Renewal
|
23 June 2021
|
25 October 2026
|
View |
|
DR-XY40238
|
Esomeprazole
|
Esoflux
|
20mg
|
Enteric-Coated Tablet
|
Proton Pump Inhibitor
|
Swiss Parenterals Pvt. Ltd.
|
India
|
Automatic Renewal
|
06 December 2021
|
26 October 2026
|
View |
|
DR-XY40246
|
Ketorolac Trometamol
|
Tral
|
30mg/mL
|
Solution For Injection
|
Non-Opioid Analgesic
|
Dongkwang Pharm. Co., Ltd.
|
Korea
|
Renewal
|
19 January 2022
|
23 February 2027
|
View |
|
DR-XY40247
|
Irbesartan
|
None
|
150 mg
|
Film-Coated Tablet
|
-
|
Lloyd Laboratories, Inc.
|
Philippines
|
-
|
14 October 2019
|
28 October 2024
|
View |
DR-XY40263_PI_01.pdf
|
DR-XY40263
|
Sirolimus
|
Rapamune
|
0.5mg
|
Sugar-Coated Tablet
|
Immunosuppressant
|
Pfizer Ireland Pharmaceuticals
|
Ireland
|
Automatic Renewal
|
24 January 2020
|
23 September 2024
|
View |
|
DR-XY40271
|
Sodium Chloride + Xylitol
|
Salinase Max
|
6.5mg/ 25mg/ mL (0.65% w/v 2.5% w/v)
|
Buffered Solution Nasal Drops
|
NASAL DECONGESTANT
|
EL Laboratories, Inc
|
Philippines
|
Automatic Renewal
|
09 October 2021
|
09 November 2026
|
View |
|
DR-XY40282
|
IRBESARTAN
|
IRBEGEN
|
150 mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blocker
|
Lloyd Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
14 October 2021
|
14 November 2026
|
View |
|
DR-XY40284
|
Forexine
|
Cefalexin (As Monohydrate)
|
500mg
|
Capsule
|
-
|
Hizon Laboratories, Inc.
|
Philippines
|
-
|
19 May 2021
|
16 November 2026
|
View |
|
DR-XY40287
|
Oxacillin (As Sodium)
|
Peoxa
|
1 g
|
Powder For Injection (Im/Iv)
|
Antibacterial (Penicillin)
|
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co. Ltd.
|
China
|
Automatic Renewal
|
06 December 2021
|
16 November 2026
|
View |
|
DR-XY40290
|
Tolnaftate
|
TOLNACTIN
|
10mg / G (1% W / W)
|
Cream
|
Antifungal
|
Lloyd Laboratores, Inc.
|
Philippines
|
Renewal
|
13 October 2021
|
14 November 2026
|
View |
|
DR-XY40302
|
Paracetamol + Phenylephrine Hydrochloride +Chlorphenamine Maleate
|
Coldezent Reformulated
|
325mg/ 20mg/ 4mg
|
Capsule
|
Analgesic/ Antipyretic/ Nasal Decongestant/ Antihistamine
|
San Marino Laboratories Corporation
|
Philippines
|
Automatic Renewal
|
26 November 2021
|
16 November 2026
|
View |
|
DR-XY40304
|
MULTIVITAMINS + MINERALS + IRON + FOLIC ACID
|
MACROBEE with Iron Forte
|
[see reverse]
|
Tablet
|
Vitamins & Minerals
|
Lloyd Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
07 December 2021
|
17 November 2026
|
View |
|
DR-XY40305
|
Famotidine + Calcium Carbonate + Magnesium Hydroxide
|
Fulzimed
|
10mg/800mg/ 165mg
|
Chewable Tablet
|
H-2 Receptor antagonist / Antacid
|
Lloyd Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
09 October 2021
|
17 November 2026
|
View |
|
DR-XY40309
|
Sildenafil (as Citrate)
|
Greatafil Max
|
100mg
|
Film-Coated Tablet
|
Phosphodiesterase-5 Inhibitor
|
Flamingo Pharmaceuticals Ltd.
|
India
|
Automatic Renewal
|
03 August 2021
|
17 November 2026
|
View |
|
DR-XY40311
|
Sodium Chloride
|
None
|
0.009
|
Solution for Infusion
|
Parenteral Electrolyte Solution
|
Marion Laboratories (Pvt.) Ltd.
|
Pakistan
|
Automatic Renewal
|
26 November 2021
|
17 November 2026
|
View |
|
DR-XY40316
|
Levodopa + Benserazide (As Hydrochloride)
|
Madopar HBS
|
100 mg/ 25 mg
|
Tablet
|
Antiparkinsonism (Dopaminergic)
|
Delpharm Milano S.r.L
|
italy
|
Initial (Variation)
|
25 August 2022
|
25 August 2027
|
View |
|
DR-XY40317
|
5% Dextrose In 0.9% Sodium Chloride
|
None
|
Formulation Each 100 mL contains: Dextrose Monohydrate- 5 g Sodium Chloride- 900 mg
|
Solution For Intravenous Infusion
|
Electrolyte Replenisher
|
Sichuan Kelun Pharmaceutical Co. Ltd.
|
China
|
Automatic Renewal
|
23 March 2021
|
22 November 2026
|
View |
|
DR-XY40319
|
Hyoscine butylbromide
|
Gascosin
|
20 mg/mL
|
Solution for injection (IV/IM/SC)
|
Anticholinergic
|
Zhejiang Ruixin Pharmaceutical Co., Ltd.
|
China
|
Automatic Renewal
|
21 September 2021
|
21 November 2026
|
View |
|
DR-XY40320
|
Folic Acid
|
Foligen
|
5 mg
|
Tablet
|
Anti-Anemic
|
La Croesus Pharma, Inc.
|
Philippines
|
Automatic Renewal
|
05 October 2021
|
28 November 2026
|
View |
|
DR-XY40321
|
Xylometazoline Hydrochloride
|
Xylonas
|
1mg/ mL (0.1%)
|
Nasal Solution (Drops)
|
Nasal Decongestant
|
Geofman Pharmaceuticals
|
Pakistan
|
Automatic Renewal
|
20 October 2021
|
21 November 2026
|